08.01.05 |
Formulary
|
 |
Arsenic Trioxide Trisenox® |
08.02.04 |
Formulary
|
 |
Atezolizumab (Tecentriq®) |
08.02.04 |
Formulary
|
 |
Axicabtagene ciloleuce (Yescarta®) |
08.02.04 |
Formulary
|
 |
Glatiramer Acetate Copaxone® |
05.03.03.02 |
Formulary
|
 |
Glecaprevir and Pibrentasvir Maviret® |
08.02.04 |
Formulary
|
 |
Immunocellular therapy containing tisagenlecleucel, autologous T cells genetically modified ex vivo using a lentiviral vector encoding an anti-CD19 chimeric antigen receptor (CAR) (Kymriah®) |
08.01 |
Formulary
|
 |
Inotuzumab ozogamicin Besponsa® |
08.02.04 |
Formulary
|
 |
Interferon Beta Betaferon® |
08.01.05 |
Formulary
|
 |
Lenvatinib Lenvima® and Kisplyx® |
08.01.05 |
Formulary
|
 |
Paclitaxel - Albumin Bound Formulation Abraxane® |
08.02.03 |
Formulary
|
 |
Rituximab MabThera®Truxima ® |
05.03.03.02 |
Formulary
|
 |
Sofosbuvir, Velpatasvir and Voxilaprevir Vosevi® |
08.02.04 |
Formulary
|
 |
Talimogene laherparepvac Imlygic® |
08.01.05 |
Formulary
|
 |
Trastuzumab emtansine Kadcyla® |
08.01.05 |
Formulary
|
 |
Trifluridine and Tipiracil Lonsurf ® |